Stryker Corp (SYK) reported third-quarter earnings for fiscal 2025, with earnings per share (EPS) of $3.19, slightly exceeding Wall Street's consensus estimate of $3.16. Revenue for the quarter reached $6.1 billion, matching analyst expectations.
The company, headquartered in Portage, Michigan, specializes in medical technology, offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Stryker employs approximately 53,000 full-time employees and is committed to improving patient and healthcare outcomes through innovative solutions.
The firm will host its earnings conference call after market close to discuss these results and provide further insights into business performance.
This earnings report underscores Stryker's alignment with market forecasts, reflecting stability in its operational performance. Investors are encouraged to review the full earnings release and listen to management's commentary for comprehensive context on the quarter's results and future outlook.
Upcoming earnings are scheduled for April 28, 2026, with EPS expected at $3.0937 and revenue projected at $6.4 billion.